Genetic Variants and Regulation of Specialized Pro-resolving Mediator
NCT04698291
Cardiovascular Diseases, Healthy
London, United Kingdom
View Trial DetailsNCT Number: NCT05472207
The aim of this study is to develop risk prediction models for the early detection of high-risk patients with structural, rhythmological or inflammatory cardiovascular diseases.
Interested in participating?
Request Info18 year and older
All sexes
Observational
Medizinische Universität Innsbruck, Universitätsklinik für Innere Medizin III, Kardiologie & Angiologie, Innsbruck, Tyrol, Austria
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: from inclusion to end of study (max. 4 years)
Time frame: from inclusion to end of study (max. 4 years)
Time frame: from inclusion to end of study (max. 4 years)
Time frame: from inclusion to end of study (max. 4 years)
Time frame: from inclusion to end of study (max. 4 years)
Time frame: from inclusion to end of study (max. 4 years)
Time frame: from inclusion to end of study (max. 4 years)
Time frame: from inclusion to end of study (max. 4 years)
Time frame: from inclusion to end of study (max. 4 years)
Contact information is provided by the study sponsor or research team.
Medical University Innsbruck
Other
"Multifactorial Risk Stratification in Acute and Chronic Cardiovascular Disease" ("riskINN ")
Acronym: riskINN
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04698291
Cardiovascular Diseases, Healthy
London, United Kingdom
View Trial DetailsNCT06227468
Cardiovascular Diseases, Chronic Disease
Chaïdári, Attica, Greece
View Trial DetailsNCT06318390
Cardiovascular Diseases, Cognition Disorders
Arlington, Texas, United States
View Trial DetailsNCT05987891
Cardiovascular Abnormalities, Cardiovascular Diseases
São Paulo, Brazil
View Trial Details